END-STAGE KIDNEY DISEASE (ESKD)

Clinical trials for END-STAGE KIDNEY DISEASE (ESKD) explained in plain language.

Never miss a new study

Get alerted when new END-STAGE KIDNEY DISEASE (ESKD) trials appear

Sign up with your email to follow new studies for END-STAGE KIDNEY DISEASE (ESKD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for dialysis patients with dangerous hormone imbalance

Disease control Completed

This study tested a drug called PLS240 for people with kidney failure on dialysis who also have a serious hormone disorder called secondary hyperparathyroidism. In the first part, 362 participants were randomly assigned to receive either the real drug or a placebo for 27 weeks. A…

Matched conditions: END-STAGE KIDNEY DISEASE (ESKD)

Phase: PHASE3 • Sponsor: Pathalys Pharma • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

END-STAGE KIDNEY DISEASE (ESKD)

Get alerted when new END-STAGE KIDNEY DISEASE (ESKD) trials appear

New hope for dialysis patients with dangerous hormone imbalance